{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:20:16Z","timestamp":1788261616157,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejim.2026.107015","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:55:38Z","timestamp":1781726138000},"page":"107015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Disease clearance in immune-mediated gastrointestinal disorders: A new standard or a semantic trap?"],"prefix":"10.1016","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0544-0414","authenticated-orcid":false,"given":"Giovanni","family":"Santacroce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6654-4911","authenticated-orcid":false,"given":"Marco Vincenzo","family":"Lenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lo Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0302-8645","authenticated-orcid":false,"given":"Antonio","family":"Di Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.107015_bib0001","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2025.07.024","article-title":"Mechanistic and therapeutic advances in immune-mediated gastrointestinal disorders","volume":"156","author":"Garabatos","year":"2025","journal-title":"J Aller Clin Immunol"},{"key":"10.1016\/j.ejim.2026.107015_bib0002","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2026.107015_bib0003","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/ibd\/izad159","article-title":"Disease clearance as a new outcome in ulcerative colitis: a systematic review and expert consensus","volume":"30","author":"D\u2019Amico","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2026.107015_bib0004","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1473-3099(12)70010-5","article-title":"Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine","volume":"12","author":"Grebely","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ejim.2026.107015_bib0005","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf040","article-title":"Novel outcomes in inflammatory bowel disease","volume":"19","author":"Jairath","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejim.2026.107015_bib0006","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ueg2.12288","article-title":"Ulcerative colitis: impact of early disease clearance on long-term outcomes - a multicenter cohort study","volume":"10","author":"D\u2019Amico","year":"2022","journal-title":"UEG J"},{"key":"10.1016\/j.ejim.2026.107015_bib0007","doi-asserted-by":"crossref","first-page":"i1453","DOI":"10.1093\/ecco-jcc\/jjae190.0928","article-title":"P0754 Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial","volume":"19","author":"Pudipeddi","year":"2025","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1016\/j.ejim.2026.107015_bib0008","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S2468-1253(25)00263-8","article-title":"Ulcerative colitis: moving beyond the mucosal dogma","volume":"11","author":"Eggermont","year":"2026","journal-title":"The Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2026.107015_bib0009","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000442","article-title":"Combined endoscopic and radiologic healing is associated with a better prognosis than endoscopic healing only in patients with crohn\u2019s disease receiving anti-TNF therapy","volume":"13","author":"Oh","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.ejim.2026.107015_bib0010","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/gutjnl-2024-333994","article-title":"Understanding tissue injury and remodelling in eosinophilic oesophagitis: development towards personalised medicine","volume":"74","author":"Santacroce","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2026.107015_bib0011","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jaci.2021.07.001","article-title":"Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)","volume":"149","author":"Ma","year":"2022","journal-title":"J Allergy Clinic Immunol"},{"key":"10.1016\/j.ejim.2026.107015_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2017.09.046","article-title":"Optimal histologic cutpoints for treatment response in patients with eosinophilic esophagitis: analysis of data from a prospective cohort study","volume":"16","author":"Reed","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2026.107015_bib0013","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2468-1253(18)30096-7","article-title":"Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study","volume":"3","author":"Shoda","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2026.107015_bib0014","doi-asserted-by":"crossref","DOI":"10.1177\/17562848251383782","article-title":"Study design of the phase IV, randomized, placebo-controlled REMOdeling with Dupilumab in Eosinophilic esophagitis Long-term (REMODEL) trial","volume":"18","author":"Dellon","year":"2025","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.ejim.2026.107015_bib0015","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jpn3.70013","article-title":"EndoFLIP distensibility index correlates with histologic findings in children with eosinophilic esophagitis","volume":"80","author":"Almazan","year":"2025","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ejim.2026.107015_bib0016","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/ajg.2017.202","article-title":"Long-term treatment of eosinophilic esophagitis with swallowed topical corticosteroids: development and evaluation of a therapeutic concept","volume":"112","author":"Greuter","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2026.107015_bib0017","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(09)60254-3","article-title":"Coeliac disease","volume":"373","author":"Di Sabatino","year":"2009","journal-title":"The Lancet"},{"key":"10.1016\/j.ejim.2026.107015_bib0018","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/jgh.16808","article-title":"Prevalence and etiologies of non-responsive celiac disease: a systematic review and meta-analysis","volume":"40","author":"Aggarwal","year":"2025","journal-title":"J Gastro Hepatol"},{"key":"10.1016\/j.ejim.2026.107015_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2026.04.031","article-title":"Optimizing histologic entry criteria for clinical trials in celiac disease involving gluten challenge","author":"Lebwohl","year":"2026","journal-title":"Clinic Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2026.107015_bib0020","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/ajg.2012.220","article-title":"Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease","volume":"107","author":"Tuire","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2026.107015_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2023-001218","article-title":"Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial","volume":"11","author":"Jairath","year":"2024","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.ejim.2026.107015_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103143","article-title":"Seronegative autoimmune diseases: a challenging diagnosis","volume":"21","author":"Lenti","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2026.107015_bib0023","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/MPG.0b013e318276a6a7","article-title":"Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease","volume":"56","author":"Ciccocioppo","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ejim.2026.107015_bib0024","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MPG.0b013e3181788282","article-title":"14 Years of eosinophilic esophagitis: clinical features and prognosis","volume":"48","author":"Spergel","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ejim.2026.107015_bib0025","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1056\/NEJMc2508023","article-title":"CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis","volume":"393","author":"M\u00fcller","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.107015_bib0026","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1136\/gutjnl-2023-331579","article-title":"Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia","volume":"73","author":"Iacucci","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2026.107015_bib0027","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/gutjnl-2025-335373","article-title":"Coeliac disease and the intestinal barrier: mechanisms of disruption and strategies for restoration","volume":"75","author":"Damianos","year":"2026","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2026.107015_bib0028","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41575-024-01035-7","article-title":"Understanding the therapeutic toolkit for inflammatory bowel disease","volume":"22","author":"Vieujean","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2026.107015_bib0029","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf200","article-title":"Automated real-time imaging of intestinal barrier integrity and molecular profiling for early outcome prediction in inflammatory bowel disease: endo-histo-barrier-omics study","volume":"19","author":"Iacucci","year":"2025","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1016\/j.ejim.2026.107015_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-09680-x","article-title":"Disrupted mucosal vascular barrier in eosinophilic esophagitis","volume":"15","author":"Lenti","year":"2025","journal-title":"Sci Rep"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526003201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526003201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:07:18Z","timestamp":1788260838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526003201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0953620526003201"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107015","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease clearance in immune-mediated gastrointestinal disorders: A new standard or a semantic trap?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107015"}}